Now in 2025, the TGA has registered Pfizer's LP.8.1 vaccine, designed specifically to target the spike protein of LP.8.1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback